Tests a needle biopsy guided by ultrasound for bladder cancer staging

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults who are having their bladder removed (radical cystectomy) for confirmed or suspected bladder urothelial cancer. It tests an ultrasound-guided needle biopsy for staging.

Age

18 years or older

Sex

All sexes can join

Disease stage

Confirmed or suspected urothelial carcinoma of the bladder, going to radical cystectomy

Earlier treatment

No earlier partial removal of the bladder or complex bladder reconstruction

Main reasons for not taking part

• History of partial cystectomy
• Complex bladder reconstruction or substitution, such as a bladder augment
• Cancer coming back in a neobladder

The registry criteria, word for word

What the trial wants to find out

This study is being done to test the feasibility and accuracy of using an ultrasound-guided core needle biopsy technique as a potential tool for staging urothelial carcinoma of the bladder (UCB).

The group in the trial

• Observational

  Patients undergo standard of care radical cystectomy and residual tissues collected undergo US core needle biopsy. Additionally, patients have their medical records reviewed on study.

  Treatment: Non-Interventional Study